These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32160411)

  • 1. Amantadine hydrochloride monitoring by dried plasma spot technique: High-performance liquid chromatography-tandem mass spectrometry based clinical assay.
    Li Y; Jiang Y; Lin T; Wan Q; Yang X; Xu G; Huang J; Li Z
    J Sep Sci; 2020 Jun; 43(12):2264-2269. PubMed ID: 32160411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants: Clinical Validation of a UPLC-MS/MS-Based Assay.
    Foerster KI; Huppertz A; Meid AD; Müller OJ; Rizos T; Tilemann L; Haefeli WE; Burhenne J
    Anal Chem; 2018 Aug; 90(15):9395-9402. PubMed ID: 29985592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried plasma spot-based liquid chromatography-tandem mass spectrometry for the quantification of methotrexate in human plasma and its application in therapeutic drug monitoring.
    Cao H; Li L; Wang S; Guo H; Ren W; Li Y; Huang J
    J Sep Sci; 2022 Mar; 45(6):1153-1161. PubMed ID: 34981894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of valproic acid using a dried plasma spot sampling device.
    Li Y; Jiang Y; Cao H; Lin H; Ren W; Huang J; Zhang J
    J Mass Spectrom; 2021 Apr; 56(4):e4603. PubMed ID: 33729629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a micro plasma collection card for the detection of homocysteine by liquid chromatography with tandem mass spectrometry.
    Yuan X; Lu Y; Xiao C; Zhu J; Zhang W; Yu C; Li S
    J Sep Sci; 2018 Nov; 41(22):4167-4176. PubMed ID: 30207427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validated method for the quantification of fosfomycin on dried plasma spots by HPLC-MS/MS: application to a pilot pharmacokinetic study in humans.
    Parker SL; Lipman J; Dimopoulos G; Roberts JA; Wallis SC
    J Pharm Biomed Anal; 2015 Nov; 115():509-14. PubMed ID: 26299527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
    Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
    Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and sensitive ultra-performance liquid chromatography tandem mass spectrometry method for determination of anlotinib in plasma and dried blood spots: Method development, validation, and clinical application.
    Zhang J; Wang W; Du J; Li C; Wang S; Han Y; Wang H; Zong H; Cheng Z; Tian X
    Rapid Commun Mass Spectrom; 2022 Nov; 36(21):e9372. PubMed ID: 35918299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability of methylmalonic acid and total homocysteine analysis in dried bloodspots.
    de Sain-van der Velden MGM; van der Ham M; Jans JJ; Visser G; van Hasselt PM; Prinsen HCMT; Verhoeven-Duif NM
    Anal Chim Acta; 2015 Jan; 853():435-441. PubMed ID: 25467488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation.
    Linder C; Hansson A; Sadek S; Gustafsson LL; Pohanka A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():116-122. PubMed ID: 29149735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: A step towards home sampling.
    Linder C; Wide K; Walander M; Beck O; Gustafsson LL; Pohanka A
    Clin Biochem; 2017 May; 50(7-8):418-424. PubMed ID: 28027888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia.
    Lee J; Jung SY; Choi MY; Park JS; Park SK; Lim SA; Cho KH; Oh SY; Ha J; Kim DW; Lee J
    J Clin Pharm Ther; 2020 Oct; 45(5):1006-1013. PubMed ID: 32022312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method.
    McCann SJ; Gillingwater S; Keevil BG; Cooper DP; Morris MR
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):161-5. PubMed ID: 12662404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dried Plasma Spots and Oral Fluid as Alternative Matrices for Therapeutic Drug Monitoring of Busulfan: Analytical Method Development and Clinical Evaluation.
    Granzotto FCN; da Silva ACC; Lizot LF; Antunes MV; Linden R
    Ther Drug Monit; 2021 Jun; 43(3):376-385. PubMed ID: 32960547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry.
    Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y
    Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass Spectrometry.
    Verweij-van Wissen CP; de Graaff-Teulen MJ; de Kanter CT; Aarnoutse RE; Burger DM
    Ther Drug Monit; 2015 Oct; 37(5):626-33. PubMed ID: 25627404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical and clinical validation of a dried blood spot assay for the determination of paclitaxel using high-performance liquid chromatography-tandem mass spectrometry.
    Andriguetti NB; Hahn RZ; Lizot LF; Raymundo S; Costa JL; da Cunha KF; Vilela RMM; Kluck HM; Schwartsmann G; Antunes MV; Linden R
    Clin Biochem; 2018 Apr; 54():123-130. PubMed ID: 29514052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Dried Blood Spots for Pharmacokinetic Monitoring of Vemurafenib Treatment in Melanoma Patients.
    Nijenhuis CM; Huitema AD; Marchetti S; Blank C; Haanen JB; van Thienen JV; Rosing H; Schellens JH; Beijnen JH
    J Clin Pharmacol; 2016 Oct; 56(10):1307-12. PubMed ID: 26918324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies.
    Xu Y; Fang W; Zeng W; Leijen S; Woolf EJ
    Anal Bioanal Chem; 2012 Dec; 404(10):3037-48. PubMed ID: 23099526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.